CELZ
Creative Medical Technology Holdings Inc

7,910
Loading...
Loading...
News
all
press releases
Retail Traders Pile Into Creative Medical After FDA Fast Tracks Degenerative Disc Disease Therapy
The company estimates that the potential market for innovative treatments for spinal disorders could exceed $20 billion by 2030.
Stocktwits·2mo ago
News Placeholder
More News
News Placeholder
New Strong Sell Stocks for July 31st
CELZ, GRFS and WHR have been added to the Zacks Rank #5 (Strong Sell) List on July 31, 2025.
Zacks·2mo ago
News Placeholder
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) Sees Large Increase in Short Interest
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ Get Free Report) was the target of a significant growth in short interest in March. As of March 15th, there was short interest...
Ticker Report·2y ago
News Placeholder
Creative Medical Technology Holdings Provides Corporate Update
Creative Medical Technology Holdings, Inc., (Creative Medical Technology or the Company) (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology...
Business Wire·2y ago
News Placeholder
12 titres de soins de sant en mouvement lors de la session du 07/03/2024
Gagnants Le titre Creative Medical Tech (NASDAQ:CELZ) a augment jeudi de 40,33% 6,68 dollars lors de la session ordinaire. Le titre Psyence Biomedical (NASDAQ:PBM) a augment de 35,29% 1,38...
Benzinga·2y ago
News Placeholder
12 titoli sanitari in movimento, sessione regolare del 07/03/2024
Titoli in rialzo Il titolo Creative Medical Tech (NASDAQ:CELZ) salito del 44,53% a 6,88 dollari durante la sessione regolare di gioved . Il titolo Psyence Biomedical (NASDAQ:PBM) ha avuto un...
Benzinga·2y ago
News Placeholder
Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
Creative Medical Technology Holdings, Inc., (NASDAQ:CELZ), a leader in biotech innovation, today announced a major stride in combating Type 1 Diabetes Mellitus (T1D). The company has secured FDA...
Business Wire·2y ago
News Placeholder
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a leader in the field of regenerative medicine with a focus on developing novel therapies in immunotherapy, endocrinology, urology...
Business Wire·2y ago

Latest CELZ News

View

Advertisement|Remove ads.

Advertisement|Remove ads.